Group 2I: HER2+ Testing; BRCA+; Surgery & Radiotherapy

Wednesday, Dec 14
2:00 pm – 3:30 pm Eastern Time (US/New York)

Poster #P1-09-11

Impact of breast surgical procedure on survival in BRCA mutated patients with invasive breast cancer: mastectomy versus conservative treatment

Poster #P1-08-07:

Educational opportunities to improve HER2 testing and use of newer therapies for HER2-positive MBC among community healthcare professionals

Mentor: Julia Maués

Julia Maués was diagnosed with breast cancer in 2013 while pregnant. Following the birth of a healthy baby boy, Julia did tests she couldn’t do while pregnant and discovered the cancer had spread to her brain, liver, and bones. After many treatment setbacks, her cancer began to respond to treatment. Cancer is part of Julia’s life, but it doesn’t define her. Her goal is to make an impact while she is alive in the lives of others dealing with this disease. She has found meaning and purpose in working with patients and researchers to make cancer research more patient-centered, innovative, and inclusive.

Twitter: @itsnot_pink

Scientist: Carmela Caballero, M.D.

Carmela is a general surgeon from the Philippines, currently working as a medical advisor for Breast International Group (BIG) in Brussels, Belgium. She and her team are involved in large scale international clinical trials on adjuvant treatment for HER2 positive breast cancer, de-escalation of radiotherapy, and molecular profiling of metastatic breast cancer. As the Steering Committee Chair of the European Society of Surgical Oncology Young Surgeon’s Alumni Club (ESSO-EYSAC), Carmela is especially interested in advancing surgical oncology research. Being a core member of the BIG Patient Partnership Initiative and BIG Asia Collaboration, Carmela is working towards the involvement of patient advocates as partners in defining research priorities and in developing clinical trials for breast cancer. To achieve balance in her life, she writes, draws and does yoga.